22 Oct DecisionRx Named 2024 Fierce Healthcare Innovation Awards Finalist
INDIANAPOLIS, October 22, 2024 – DecisionRx, Inc., a value-based healthcare company reducing the cost of care by helping individuals eliminate medication failure, today announced that the company’s Medication Therapy Optimization (MTO) platform has been recognized as a finalist of the 2024 Fierce Healthcare Innovation Awards in the Clinical Information Management category. Winners will be announced across six total categories on December 2, 2024 in the Fierce Life Sciences’ Innovation Report, which will feature spotlights and interviews of all category winners.
“Recognition of our Medication Therapy Optimization (MTO) platform as a finalist by Fierce Life Sciences speaks to the real-world health transformation and cost savings we bring our clients and prospective clients,” said DecisionRx Co-founder and president Travis Morgan. “Medication failure accounts for at least 16% of total healthcare spending. By using pharmacogenomics-driven insights we can improve health outcomes and work to eliminate trial-and-error prescribing. We look forward to seeing the 2024 winners in December and would like to congratulate all of the finalists on this year’s list.”
The Fierce Life Sciences Innovation Awards showcase outstanding innovations that drive improvements in healthcare and are transforming the industry. Nominations were judged by a panel to determine which companies demonstrate innovative solutions that have the greatest potential to save money, engage patients, or revolutionize the industry.
To see the full list of finalists, and for more information about the program, visit https://fiercehealthcareinnovationawards.fiercelifesciences.com/.
About DecisionRx
DecisionRx is a technology-enabled healthcare services company, improving patient outcomes and reducing healthcare costs by helping physicians optimize prescribing decisions for their patients. DecisionRx clinical pharmacists work on patients’ behalf to mitigate medication failure by making personalized medication recommendations to prescribers, informed by the latest clinical and data-science, and delivered in a value-based care model. Medication failure accounts for at least 16% of total healthcare spending, and medication therapy optimization has been shown to reduce total annualized cost of care by $3,600 for Medicare patients and $1,200 for patients under age 65.
Media Contacts
Alexis Feinberg
ICR Westwicke on behalf of DecisionRx
646-277-1252